You are here

  • Home
  • Archive
  • Volume 95, Issue 9
  • T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination

Article metrics

Article menu
Multiple sclerosis
Original research
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination

 

Online download statistics by month:

Online download statistics by month: March 2024 to September 2024

AbstractFullPdf
Mar 202418617476
Apr 2024536510210
May 202416917075
Jun 202413913753
Jul 2024959550
Aug 202430129987
Sep 2024147140237
Total15731525788